华西医学

华西医学

双歧杆菌乳杆菌三联活菌片联合聚乙二醇4000 散治疗老年慢性便秘的临床研究

查看全文

目的 观察双歧杆菌乳杆菌三联活菌片联合聚乙二醇 4000 散治疗老年人慢性便秘的临床疗效。 方法 将 2015 年 4 月—2016 年 4 月在老年医学中心门诊和住院的 120 例老年慢性便秘患者随机分配至 A 组(聚乙二醇 4000 散联合安慰剂片)和 B 组(双歧杆菌乳杆菌三联活菌片联合聚乙二醇 4000 散),每组各 60 例。比较两组患者治疗前后 Bristol 粪便性状评分(Bristol Stool Form Scale,BSFS)、便秘患者症状自评问卷(Patient Assessment of Constipation Symptom,PAC-SYM)、便秘相关残疾量表(Constipation Related Disability,CRDS)等临床指标,评估临床疗效,记录药物的不良反应。 结果 A 组患者治疗前 BSFS、PAC-SYM、CRDS 分别为(1.98±0.77)、(37.87±4.12)、(31.03±3.19)分,治疗后分别为(3.87±0.82)、(28.55±2.15)、(18.56±1.80)分;B 组患者治疗前 BSFS、PAC-SYM、CRDS 分别为(2.03±0.78)、(36.25±4.98)、(30.28±3.56)分,治疗后分别为(4.80±0.75)、(19.73±3.42)、(13.80±2.36)分。两组患者治疗后各临床观察指标较治疗前均明显改善,差异有统计学意义(P<0.05);组间比较,B 组临床指标较 A 组改善更明显,差异有统计学意义(P<0.05)。未观察到严重不良反应。 结论 双歧杆菌乳杆菌三联活菌片联合聚乙二醇 4000 散对改善老年慢性便秘有理想效果。

Objective To explore the effect of triple viable bifidobacterium lactobacillus tablets combined with polyethylene glycol 4000 on elderly patients with chronic constipation. Methods This pilot study was conducted at the Center of Gerontology and Geriatrics, West China Hospital. A total of 120 patients with chronic constipation, aged 60 years or older, treated between April 2015 and April 2016 were enrolled, and randomly assigned into group A (polyethylene glycol 4000) and group B (triple viable bifidobacterium lactobacillus tablets combined with polyethylene glycol 4000) with 60 patients in each. All the patients were estimated before and after the treatment with Bristol Stool Form Scale (BSFS), Patient Assessment of Constipation Symptom (PAC-SYM) and Constipation Related Disability (CRDS), and the adverse drug reactions were observed. Results In group A, before the treatment, the scores of BSFS, PAC-SYM and CRDS were 1.98±0.77, 37.87±4.12 and 31.03±3.19, respectively; while after the treatment, the scores were 3.87±0.82, 28.55±2.15 and 18.56±1.80, respectively, which were all significantly improved (P<0.05). In group B, before the treatment, the scores of BSFS, PAC-SYM and CRDS were 2.03±0.78, 36.25±4.98 and 30.28±3.56, respectively; while after the treatment, the scores were 4.80±0.75, 19.73±3.42 and 13.80±2.36, respectively, which were all significantly improved (P<0.05). The improvement of constipation in group B was significantly better than that in group A after treatment (P<0.05). There was no adverse drug reaction observed. Conclusion Triple viable bifidobacterium lactobacillus tablets combined with polyethylene glycol 4000 may be an effective therapy for elderly patients with chronic constipation.

关键词: 双歧杆菌乳杆菌三联活菌片; 聚乙二醇 4000 散; 老年人; 慢性便秘

Key words: Triple viable bifidobacterium lactobacillus tablets; Polyethylene glycol 4000; Elderly; Chronic constipation

引用本文: 何馥倩, 李晓冉, 黄晓丽. 双歧杆菌乳杆菌三联活菌片联合聚乙二醇4000 散治疗老年慢性便秘的临床研究. 华西医学, 2017, 32(12): 1872-1875. doi: 10.7507/1002-0179.201604244 复制